-
Tens of billions of markets to be broken! The popularity of "orphan drugs" in China continues to rise
Time of Update: 2022-12-30
In order to encourage domestic pharmaceutical companies to increase the research and development and production of rare disease drugs, in recent years, national government departments have successively issued a series of incentive policies.
-
The domestic pharmaceutical equipment industry is growing against the trend, and its revenue may exceed 25 billion yuan in 2023
Time of Update: 2022-12-30
Data show that in recent years, the sales of the pharmaceutical equipment industry have shown a gradual improvement trend, and it is predicted that the sales of this market will reach 23.
-
Xu Haoyu: Life and health enterprises have the responsibility to establish a healthy and civilized concept
Time of Update: 2022-12-30
Boao, November 28, Xinhuanet (Wu Qilong) From November 25 to 28, the 2022 Boao Forum for Chinese Entrepreneurs was held in Boao, Hainan. Xu Haoyu, secretary of the party committee, chairman and gener
-
In 2023, the opportunities in the pharmaceutical sector look at two keywords
Time of Update: 2022-12-30
On the one hand, "anti-epidemic" related products and anti-cold drugs and their industrial chain are still expected to benefit, including anti-cold drugs (including traditional Chinese medicine) with high performance certainty, retail pharmacies, household equipment such as oxygen generators, antigen testing, etc.
-
The pharmaceutical sector has changed! Guizhou Sanli, Saili Medical and many other stocks rose to the limit
Time of Update: 2022-12-30
According to the analysis, the reasons for the change in the stock include: the company is a traditional Chinese medicine enterprise, with products such as Huo Xiang Zhengqi Capsules, Angong Niuhuang Pills, and Suhe Xiang Pills, and has launched new drug research and registration projects for 6 classic Chinese medicine series.
-
License-in "not fragrant"? Another IPO of the science and technology innovation board of pharmaceutical companies was pressed the "pause button"
Time of Update: 2022-12-30
【Pharmaceutical Network Market Analysis】In recent years, with the normalization of centralized procurement, medical insurance control fees and other policies, the domestic pharmaceutical industry has
-
Establish a "white list" management system to promote pharmaceutical companies to expand production and increase the supply of key drug markets
Time of Update: 2022-12-30
Jiao Yahui, Director of the Department of Medical Affairs of the National Health Commission:In response to the shortage of drugs in some regions caused by the recent increase in the number of patients and the surge in drug demand, the relevant person in charge of the Ministry of Industry and Information Technology introduced that enterprises have been promoted to rapidly stabilize production, expand capacity and expand production, and increase the supply of key drug markets.
-
The market space for biopharmaceutical disposable consumables and equipment is broad, and pharmaceutical companies will usher in benefits
Time of Update: 2022-12-30
In the future, with the commissioning of Chutian Siyote plant, the industry is expected to provide guarantee for the production capacity of Chutian Technology's disposable bioreactors, liquid preparation bags, storage bags and their membranes.
-
The number of people vaccinated with the third dose of the new crown vaccine in Japan accounts for 67.4% of the country's total population
Time of Update: 2022-12-30
(End) According to the latest data released by the Japanese government on the 19th, the number of people who have completed the third dose of the new crown vaccine in Japan is 84911922, accounting for 67.
-
Beijing makes every effort to ensure the supply of medical supplies On the 12th, 25 million antigen reagents were released at one time
Time of Update: 2022-12-30
At present, the epidemic situation in Beijing is still at a high level, and the demand for epidemic prevention and control drugs and medical devices has increased sharply. Wang Houting, deputy direct
-
Guangshengtang and other 10 pharmaceutical stocks rose to the limit, and the industry believes that the sector will meet the opportunity
Time of Update: 2022-12-30
, a subsidiary of its innovative drug holding company, was successfully enrolled in the drug administration on March 11, 2022, marking that the clinical trial of GST-HG151 project has entered the substantive development stage 。 In addition, in December 21, Fujian Guangsheng Zhonglin Biotechnology Co.
-
China Pharmaceutical closed 3 consecutive limit boards! The stock has risen 23 times in the past year
Time of Update: 2022-12-30
In order to strengthen Paxlovid's supply in the Chinese market, in addition to reaching cooperation with China Pharmaceutical, Huahai Pharmaceutical announced on August 18 that it reached a production and supply agreement with Pfizer.
-
Shenyang Medical Insurance Launches New Policy! Reduce the burden of medical expenses for serious and extraordinarily serious diseases for people in need
Time of Update: 2022-12-30
According to a press conference held by the Information Office of Shenyang Municipal Government on December 13, the Implementation Measures for Shenyang's Improvement of Medical Insurance and Assista
-
The first China Young Doctors' Minimally Invasive Ablation Professional Skills Competition in South China is about to start
Time of Update: 2022-12-30
Announcement of the event11:10-11:15 Results announced Moderator11:15-11:25 Mentor group11:25-11:30 Competition Summary Professor Xiao YueyongHostInterventional Minimally Invasive Treatment Professional Committee of China Medical Education AssociationMinimally Invasive Tumor Treatment Professional Committee of Chinese Anti-Cancer AssociationAsian Society of CryotherapyAssistedNanjing Yigao Medical Technology Co.
-
In the past half month, the market price of some medicinal materials has nearly doubled
Time of Update: 2022-12-30
In addition, some people said that with the optimization of epidemic prevention and control policies, coupled with the significant increase in people's demand for seasonal standing drugs in winter, drug manufacturers have concentrated on purchasing raw materials of Chinese medicinal materials, resulting in the opening of the 'fast-moving consumer goods' model from APIs to finished products to chain pharmacies, and the market prices of Chinese medicinal materials for heat and detoxification continue to rise.
-
Leebang @RSNA 2022, open the multi-layout of smart ultrasound!
Time of Update: 2022-12-30
Create a global localized closed-loop ecological chainThe ultrasound business continues to grow rapidlyAs an "old friend" of RSNA, Lee Bon has shown the world the latest technological breakthroughs and innovative achievements of Lipon Ultrasound, which on the other hand reflects the hard power of Lee Bon's global localization.
-
Moving forward in the direction guided by Jingqi - a record of the extraordinary development of Yangzijiang Pharmaceutical Group in ten years
Time of Update: 2022-12-30
Author: China Medical News Feng Yuhao"The report of the 20th National Congress of the Communist Party of China put forward important expressions such as 'high-quality development is the primary task
-
Netizens "corrected" Lianhua Qingwei? Demystifying the mystery behind the "misunderstanding"
Time of Update: 2022-12-30
Another question appeared in the introduction of the indications, Lianhua Qingwen packaging box and instructions show that "used to treat influenza is a heat poisonous attack lung certificate", some people questioned whether the "certificate" here should be "symptoms"?In this regard, Director Cui Hongsheng explained that the "evidence" and "disease" in Chinese medicine have different connotations.
-
There is a large space for domestic substitution of pharmaceutical equipment, and pharmaceutical companies have rushed to the market!
Time of Update: 2022-12-30
Chuangzhi Technology plans to invest 550 million yuan this time, and the funds raised will be used for high-end pharmaceutical equipment industrialization construction projects, R&D center construction projects, and supplementary working capital.
-
Sales of cold medicine, antiviral, antigen reagents are hot! Positive for pharmacies' Q4 recovery
Time of Update: 2022-12-30
In addition, the heads of listed pharmacy chains said that the current demand for new crown antigen test kits is large, and they are actively communicating with suppliers to step up the supply of reserve supplies.
